1352 related articles for article (PubMed ID: 18495445)
21. Preparation of biodegradable microparticles using solution-enhanced dispersion by supercritical fluids (SEDS).
Ghaderi R; Artursson P; Carlfors J
Pharm Res; 1999 May; 16(5):676-81. PubMed ID: 10350010
[TBL] [Abstract][Full Text] [Related]
22. Preparation and characterization of 5-fluorouracil-loaded PLLA-PEG/PEG nanoparticles by a novel supercritical CO2 technique.
Zhang C; Li G; Wang Y; Cui F; Zhang J; Huang Q
Int J Pharm; 2012 Oct; 436(1-2):272-81. PubMed ID: 22721846
[TBL] [Abstract][Full Text] [Related]
23. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
24. Formulation and evaluation of biodegradable nanoparticles for the oral delivery of fenretinide.
Graves RA; Ledet GA; Glotser EY; Mitchner DM; Bostanian LA; Mandal TK
Eur J Pharm Sci; 2015 Aug; 76():1-9. PubMed ID: 25933716
[TBL] [Abstract][Full Text] [Related]
25. Development of Fe3O4-poly(L-lactide) magnetic microparticles in supercritical CO2.
Chen AZ; Kang YQ; Pu XM; Yin GF; Li Y; Hu JY
J Colloid Interface Sci; 2009 Feb; 330(2):317-22. PubMed ID: 19036387
[TBL] [Abstract][Full Text] [Related]
26. Preparation and in vitro evaluation of etoposide-loaded PLGA microspheres for pulmonary drug delivery.
Feng R; Zhang Z; Li Z; Huang G
Drug Deliv; 2014 May; 21(3):185-92. PubMed ID: 24107001
[TBL] [Abstract][Full Text] [Related]
27. Unintended potential impact of perfect sink conditions on PLGA degradation in microparticles.
Klose D; Delplace C; Siepmann J
Int J Pharm; 2011 Feb; 404(1-2):75-82. PubMed ID: 21056644
[TBL] [Abstract][Full Text] [Related]
28. Altering the drug release profiles of double-layered ternary-phase microparticles.
Lee WL; Loei C; Widjaja E; Loo SC
J Control Release; 2011 May; 151(3):229-38. PubMed ID: 21352877
[TBL] [Abstract][Full Text] [Related]
29. Preparation and characterization of PLGA microspheres by the electrospraying method for delivering simvastatin for bone regeneration.
Nath SD; Son S; Sadiasa A; Min YK; Lee BT
Int J Pharm; 2013 Feb; 443(1-2):87-94. PubMed ID: 23291448
[TBL] [Abstract][Full Text] [Related]
30. Effect of Particle Size on Drug Loading and Release Kinetics of Gefitinib-Loaded PLGA Microspheres.
Chen W; Palazzo A; Hennink WE; Kok RJ
Mol Pharm; 2017 Feb; 14(2):459-467. PubMed ID: 27973854
[TBL] [Abstract][Full Text] [Related]
31. PLGA microdevices for retinoids sustained release produced by supercritical emulsion extraction: continuous versus batch operation layouts.
Porta GD; Campardelli R; Falco N; Reverchon E
J Pharm Sci; 2011 Oct; 100(10):4357-67. PubMed ID: 21638283
[TBL] [Abstract][Full Text] [Related]
32. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
Chaw CS; Yang YY; Lim IJ; Phan TT
J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
[TBL] [Abstract][Full Text] [Related]
33. Preparation and physicochemical characterization of T-OA PLGA microspheres.
Fu J; Dong XX; Zeng ZP; Yin XB; Li FW; Ni J
Chin J Nat Med; 2017 Dec; 15(12):912-916. PubMed ID: 29329648
[TBL] [Abstract][Full Text] [Related]
34. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
[TBL] [Abstract][Full Text] [Related]
35. Formation of nanoparticles of a hydrophilic drug using supercritical carbon dioxide and microencapsulation for sustained release.
Thote AJ; Gupta RB
Nanomedicine; 2005 Mar; 1(1):85-90. PubMed ID: 17292062
[TBL] [Abstract][Full Text] [Related]
36. Improvement of the antibacterial activity of daptomycin-loaded polymeric microparticles by Eudragit RL 100: an assessment by isothermal microcalorimetry.
Ferreira IS; Bettencourt A; Bétrisey B; Gonçalves LM; Trampuz A; Almeida AJ
Int J Pharm; 2015 May; 485(1-2):171-82. PubMed ID: 25772414
[TBL] [Abstract][Full Text] [Related]
37. Sustained release hGH microsphere formulation produced by a novel supercritical fluid technology: in vivo studies.
Jordan F; Naylor A; Kelly CA; Howdle SM; Lewis A; Illum L
J Control Release; 2010 Jan; 141(2):153-60. PubMed ID: 19772878
[TBL] [Abstract][Full Text] [Related]
38. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.
Sun B; Ranganathan B; Feng SS
Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985
[TBL] [Abstract][Full Text] [Related]
39. Formulation of porous poly(lactic-co-glycolic acid) microparticles by electrospray deposition method for controlled drug release.
Hao S; Wang Y; Wang B; Deng J; Zhu L; Cao Y
Mater Sci Eng C Mater Biol Appl; 2014 Jun; 39():113-9. PubMed ID: 24863206
[TBL] [Abstract][Full Text] [Related]
40. Formulation of anastrozole microparticles as biodegradable anticancer drug carriers.
Zidan AS; Sammour OA; Hammad MA; Megrab NA; Hussain MD; Khan MA; Habib MJ
AAPS PharmSciTech; 2006 Jul; 7(3):61. PubMed ID: 17025242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
